arrow
返回
D

Douglas W.P. Hay

University of Graz

50H指数
206论文数
8.2K被引数
收录论文 35
发表时间
Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery
err2017-05-25
err211
errOAAI
errMehta, R. H.; Leimberger, J. D.; van Diepen, S.; Meza, J.; Wang, A.; Jankowich, R.; Harrison, R. W.; Hay, D.; Fremes, S.; Duncan, A.; Soltesz, E. G.; Luber, J.; Park, S.; Argenziano, M.; Murphy, E.; Marcel, R.; Kalavrouziotis, D.; Nagpal, D.; Bozinovski, J.; Toller, W.; Heringlake, M.; Goodman, S. G.; Levy, J. H.; Harrington, R. A.; Anstrom, K. J.; Alexander, J. H.
err分享
err收藏
Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial
err2016-12-01
err23
PREAI
errMehta, Rajendra H.; Van Diepen, Sean; Meza, James; Bokesch, Paula; Leimberger, Jeffrey D.; Tourt-Uhlig, Sandra; Swartz, Merri; Parrotta, Jodi; Jankowich, Rachael; Hay, Douglas; Harrison, Robert W.; Fremes, Stephen; Goodman, Shaun G.; Luber, John; Toller, Wolfgang; Heringlake, Matthias; Anstrom, Kevin J.; Levy, Jerrold H.; Harrington, Robert A.; Alexander, John H.
err分享
err收藏
Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases
err2013-05-01
err66
PREAI
errSalmon, Michael; Luttmann, Mark A.; Foley, James J.; Buckley, Peter T.; Schmidt, Dulcie B.; Burman, Miriam; Webb, Edward F.; DeHaas, Christopher J.; Kotzer, Charles J.; Barrett, Victoria J.; Slack, Robert J.; Sarau, Henry M.; Palovich, Michael R.; Laine, Dramane I.; Hay, Douglas W. P.; Rumsey, William L.
err分享
err收藏
In vitro and in vivo pharmacological profile of PL-3994, a novel cyclic peptide (Hept-cyclo(Cys-His-Phe-D-Ala-Gly-Arg-D-Nle-Asp-Arg-Ile-Ser-Cys)-Tyr-[Arg mimetic]-NH2) natriuretic peptide receptor-A agonist that is resistant to neutral endopeptidase and acts as a bronchodilator
err2013-04-01
err23
errOAAI
errEdelson, Jeffrey D.; Makhlina, Marie; Silvester, Kevin R.; Vengurlekar, Shailesh S.; Chen, Xiaomei; Zhang, Jie; Koziol-White, Cynthia J.; Cooper, Philip R.; Hallam, Trevor J.; Hay, Douglas W. P.; Panettieri, Reynold A., Jr.
err分享
err收藏
err分享
err收藏
Differential modulation of endothelin ligand-induced contraction in isolated tracheae from endothelin B (ETB) receptor knockout mice
err2009-01-29
err7
errOAAI
errHay, DWP; Douglas, SA; Ao, ZH; Moesker, RM; Self, GJ; Rigby, PJ; Luttmann, MA; Goldie, RG
err分享
err收藏
Polymorphisms in the endothelin-1 (EDN1) are associated with asthma in two populations
err2007-10-25
err28
PREAI
errZhu, G.; Carlsen, K.; Carlsen, K-H; Lenney, W.; Silverman, M.; Whyte, M. K.; Hosking, L.; Helms, P.; Roses, A. D.; Hay, D. W.; Barnes, M. R.; Anderson, W. H.; Pillai, S. G.
err分享
err收藏
The lipoxin receptor ALX:: Potent ligand-specific and stereoselective actions in vivo
err2006-09-01
err473
PREAI
errChiang, Nan; Serhan, Charles N.; Dahlen, Sven-Erik; Drazen, Jeffrey M.; Hay, Douglas W. P.; Rovati, G. Enrico; Shimizu, Takao; Yokomizo, Takehiko; Brink, Charles
err分享
err收藏
International Union of Pharmacology XLIV.: Nomenclature for the oxoeicosanoid receptor
err2004-03-01
err58
PREAI
errBrink, C; Dahlén, SE; Drazen, J; Evans, JF; Hay, DWP; Rovati, GE; Serhan, CN; Shimizu, T; Yokomizo, T
err分享
err收藏
International union of pharmacology - XXXVII. Nomenclature for leukotriene and lipoxin receptors
err2003-03-01
err274
PREAI
errBrink, C; Dahlen, SE; Drazen, J; Evans, JF; Hay, DWP; Nicosia, S; Serhan, CN; Shimizu, T; Yokomizo, T
err分享
err收藏
A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit
err2002-12-01
err179
errOAAI
errPodolin, PL; Bolognese, BJ; Foley, JJ; Schmidt, DB; Buckley, PT; Widdowson, KL; Jin, Q; White, JR; Lee, JM; Goodman, RB; Hagen, TR; Kajikawa, O; Marshall, LA; Hay, DWP; Sarau, HM
err分享
err收藏
Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pig's
err2002-01-01
err78
PREAI
errHay, DWP; Giardina, GAM; Griswold, DE; Underwood, DC; Kotzer, CJ; Bush, B; Potts, W; Sandhu, P; Lundberg, D; Foley, JJ; Schmidt, DB; Martin, LD; Kilian, D; Legos, JJ; Barone, FC; Luttmann, MA; Grugni, M; Raveglia, LF; Sarau, HM
err分享
err收藏
Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists
err2001-04-25
err57
PREAI
errBlaney, FE; Raveglia, LF; Artico, M; Cavagnera, S; Dartois, C; Farina, C; Grugni, M; Gagliardi, S; Luttmann, MA; Martinelli, M; Nadler, GMMG; Parini, C; Petrillo, P; Sarau, HM; Scheideler, MA; Hay, DWP; Giardina, GAM
err分享
err收藏
Molecular and pharmacological characterization of the murine tachykinin NK3 receptor
err2001-02-01
err12
PREAI
errSarau, HM; Feild, JA; Ames, RS; Foley, JJ; Nuthulaganti, P; Schmidt, DB; Buckley, PT; Elshourbagy, NA; Brawner, ME; Luttmann, MA; Giardina, GAM; Hay, DWP
err分享
err收藏
Evidence that the proposed novel human neurokinin-4 receptor is pharmacologically similar to the human neurokinin-3 receptor but is not of human origin
err2000-09-01
err11
PREAI
errSarau, HM; Mooney, JL; Schmidt, DB; Foley, JJ; Buckley, PT; Giardina, GAM; Wang, DY; Lee, JA; Hay, DWP
err分享
err收藏